Skip to content
OpenCapital
Get started

MiniMed Group MMED Investments - Amortized Cost Basis

Other financials

Income statement

See full
Revenue$790.0M+15.0%
Gross profit$362.0M-8.4%
Operating income-$100.0M-576%
Net income-$119.0M-1,090%
EPS (diluted)-$0.47-1,075%

Balance sheet

See full
Cash & equivalents$10.0M0.0%
Total debt$61.0M—
Total equity$3.5B-0.7%
Total assets$4.3B—

Cash flow

See full
Operating cash flow-$27.0M-147%
CapEx$167.0M+22.8%
Free cash flow-$194.0M-146%

Valuation

See full
Market cap$3.86B—

Returns & leverage

See full
Debt / equity0×—
Current ratio1.6×—

Where this comes from

Reported directly by MiniMed Group in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: MiniMed Group ’s 10-Q, filed April 17, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is MiniMed Group 's investments - amortized cost basis?
MiniMed Group (MMED) reported investments - amortized cost basis of $72M in Q1 2026.